Among the assessed therapies, a significant difference was noted only in the frequency of use of SGLT2 inhibitors (flozins), which were used significantly more frequently in the HFrEF group, in accordance with current treatment recommendations; other therapeutic and clinical differences did not reach statistical significance.
← all excerpts
The impact of decreased left ventricular ejection fraction on neutrophil extracellular trap (NET) formation measured by citrullinated histone H3 (citH_3) concentration.
1
—
—